site-specific bleeding

ESC: Pfizer, BMS' Eliquis tops Xarelto, vitamin K drugs for site-specific bleeding risks in French real-world study
Fierce Pharma
Mon, 08/31/20 - 10:49 am
Pfizer
Bristol-Myers Squibb
Eliquis
Xarelto
site-specific bleeding
RWE
ESC